Nialamide


Nialamide is a non-selective, irreversible monoamine oxidase inhibitor of the hydrazine class that was used as an antidepressant. It was withdrawn by Pfizer several decades ago due to the risk of hepatotoxicity.
The antiatherogenic activity of nialamide was used to design pyridinolcarbamate.